The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
LIVER TRANSPLANTATION FOR CHOLANGIOCARCINOMA: RESULTS IN 207 PATIENTS1
Abstract
BACKGROUND: Because of the high incidence of recurrent tumor, many surgeons have become disenchanted with transplantation as a treatment for cholangiocarcinoma. METHODS: The Cincinnati Transplant Tumor Registry database was used to examine 207 patients who underwent liver transplantation for otherwise unresectable cholangiocarcinoma or cholangiohepatoma. Specific factors evaluated included tumor size, presence of multiple nodules, evidence of tumor spread at surgery, and treatment with adjuvant chemotherapy and/or radiation therapy. Incidentally found tumors were compared to tumors that were known or suspected to be present before transplantation. RESULTS: The 1, 2, and 5-year survival estimates using life table analysis were 72, 48, and 23%. Fifty-one percent of patients had recurrence of their tumors after transplantation and 84% of recurrences occurred within 2 years of transplantation. Survival after recurrence was rarely more than 1 year. Forty-seven percent of recurrences occurred in the allograft and 30% in the lungs. Tumor recurrence, and evidence of tumor spread at the time of surgery, were negative prognostic variables. There were no positive prognostic variables. Patients with incidentally found cholangiocarcinomas did not have improved survival over patients with known or suspected tumors. A small number of patients survived for more than 5 years without recurrence. However, this group had no variable in common that would aid in the selection of similar patients in the future. CONCLUSIONS: Because of the high rate of recurrent tumor and lack of positive prognostic variables, transplantation should seldom be used as a treatment for cholangiocarcinoma. For transplantation to be a viable treatment in the future, more effective adjuvant therapies are necessary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burke, E. C., Jarnagin, W. R., Hochwald, S. N., Pisters, P. W. T., Fong, Y., & Blumgart, L. H. (1998) · Annals of Surgery · doi:10.1097/00000658-199809000-00011 · Cited by 468
Goss, J. A., Shackleton, C. R., Farmer, D. G., Arnaout, W. S., Seu, P., Markowitz, J. S., Martin, P., Stribling, R. J., Goldstein, L. I., & Busuttil, R. W. (1997) · Annals of Surgery · doi:10.1097/00000658-199705000-00004 · Cited by 328
(2011) · Hepatogastroenterology · doi:10.5754/hge10288 · Cited by 307
Perihilar Cholangiocarcinoma Postoperative Radiotherapy Does Not Improve Survival
Pitt, H. A., Nakeeb, A., Abrams, R. A., Coleman, J., Piantadosi, S., Yeo, C. J., Lillemoe, K. D., & Cameron, J. L. (1995) · Annals of Surgery · doi:10.1097/00000658-199506000-00017 · Cited by 299
Liver Resection for Hilar and Peripheral Cholangiocarcinomas: A Study of 62 Cases
Madariaga, J. R., Iwatsuki, S., Todo, S., Lee, R. G., Irish, W., & Starzl, T. E. (1998) · Annals of Surgery · doi:10.1097/00000658-199801000-00011 · Cited by 254
Orthotopic Liver Transplantation for Primary Sclerosing Cholangitis
MARSH, J. W., IWATSUKI, S., MAKOWKA, L., ESQUIVEL, C. O., GORDON, R. D., TODO, S., TZAKIS, A., MILLER, C., THIEL, D. V., & STARZL, T. E. (1988) · Annals of Surgery · doi:10.1097/00000658-198801000-00005 · Cited by 253
Treatment of Hilar Cholangiocarcinoma (Klatskin Tumors) with Hepatic Resection or Transplantation
Iwatsuki, S., Todo, S., Marsh, W. J., Madariaga, J. R., Lee, R. G., Dvorchik, I., Fung, J. J., & Starzl, T. E. (1998) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(98)00207-5 · Cited by 251
“Natural History” of Unresected Cholangiocarcinoma: Patient Outcome After Noncurative Intervention
Farley, D. R., Weaver, A. L., & Nagorney, D. M. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.5.425 · Cited by 232
Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma
McMasters, K. M., Tuttle, T. M., Leach, S. D., Rich, T., Cleary, K. R., Evans, D. B., & Curley, S. A. (1997) · The American Journal of Surgery · doi:10.1016/s0002-9610(97)00203-1 · Cited by 220
Is liver transplantation indicated for cholangiocarcinoma?
Goldstein, R. M., Stone, M., Tillery, G. W., Senzer, N., Levy, M., Husberg, B. S., Gonwa, T., & Klintmalm, G. (1993) · The American Journal of Surgery · doi:10.1016/s0002-9610(05)80696-8 · Cited by 159
Cited by
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Banales, J. M., Marin, J. J. G., Lamarca, A., Rodrigues, P. M., Khan, S. A., Roberts, L. R., Cardinale, V., Carpino, G., Andersen, J. B., Braconi, C., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0310-z · Cited by 2,411
Guba, M., von Breitenbuch, P., Steinbauer, M., Koehl, G., Flegel, S., Hornung, M., Bruns, C. J., Zuelke, C., Farkas, S., Anthuber, M., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-128 · Cited by 1,739
Martin, P., DiMartini, A., Feng, S., Brown, R., & Fallon, M. (2014) · Hepatology · doi:10.1002/hep.26972 · Cited by 1,045
Khan, S. A., Thomas, H. C., Davidson, B. R., & Taylor-Robinson, S. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67530-7 · Cited by 1,042
Rea, D. J., Heimbach, J. K., Rosen, C. B., Haddock, M. G., Alberts, S. R., Kremers, W. K., Gores, G. J., & Nagorney, D. M. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000179678.13285.fa · Cited by 693
Metadata
- Authors
- Meyer, C. G., Penn, I., & James, L.
- Venue
- Transplantation
- Published
- 2000-04
- Volume
- 69
- Issue
- 8
- Pages
- 1633-1637
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2115288936
- Cited by
- 502
- References
- 14
- FWCI
- 14.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: LIVER TRANSPLANTATION FOR CHOLANGIOCARCINOMA: RESULTS IN 207 PATIENTS1. https://app.cochat.ai/papers/10.1097/00007890-200004270-00019
- The paper
- Meyer, C. G., Penn, I., & James, L. (2000). LIVER TRANSPLANTATION FOR CHOLANGIOCARCINOMA: RESULTS IN 207 PATIENTS1. Transplantation. https://doi.org/10.1097/00007890-200004270-00019
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.